View More View Less
  • 1 Semmelweis University Department of Dermatology, Venerology and Dermatooncology Budapest Hungary
  • | 2 Hungarian Defence Forces Research Institute of Military Health Centre Budapest Hungary
  • | 3 Semmelweis University Institute of Medical Microbiology Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Emergence and spread of antimicrobial resistance in Neisseria gonorrhoeae is a major public health concern worldwide. The current study aims to determine the antimicrobial resistance in N. gonorrhoeae and associated molecular typing to enhance gonococcal antimicrobial surveillance in Hungary. In the National N. gonorrhoeae Reference Laboratory of Hungary 187 N. gonorrhoeae infections were detected in 2013, antibiograms were determined for all the isolated strains, and 52 (one index strain from every sexually contact related group) of them were also analysed by the N. gonorrhoeae multi-antigen sequence typing (NG-MAST) method. Twenty-two different NG-MAST sequence types (STs) were identified, of which 8 STs had not been previously described. In Hungary, the highly diversified gonococcal population displayed high resistance to penicillin, ciprofloxacin and tetracycline (the antimicrobials previously recommended for gonorrhoea treatment). Resistance to the currently recommended extended spectrum cephalosporines were rare: only two of the expected strains, an ST 1407 and an ST 210, had cefixime MIC above the resistance breakpoint. By the revision of our National Treatment Guideline, it must be considered, that the azithromycin resistance is about 60% among the four most frequently isolated STs in Hungary.

  • European Centre for Disease Prevention and Control (ECDC): Sexually Transmitted Infections in Europe, 1990–2010. Stockholm: ECDC; 2012. Available from: http://www.ecdc.europa.eu/en/publications/Publications/201206-Sexually-Transmitted-Infections-Europe-2010.pdf

    '', in Sexually Transmitted Infections in Europe, 1990–2010 , (2012 ) -.

  • Fleming, D.T., Wasserheit, J.N.: From epidemiological synergy to public health policy and practice: the contribution of other STD to sexual transmission of HIV infection. Sex Transm Infect 75, 3–17 (1999).

    Wasserheit J.N. , 'From epidemiological synergy to public health policy and practice: the contribution of other STD to sexual transmission of HIV infection ' (1999 ) 75 Sex Transm Infect : 3 -17.

    • Search Google Scholar
  • Golparian, D., Hellmark, B., Fredlund, H., Unemo, M.: Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden Daniel Golparian, Bengt Hellmark, Hans Fredlund, Magnus Unemo. Sex Transm Infect 86, 454–460 (2010).

    Unemo M. , 'Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden Daniel Golparian, Bengt Hellmark, Hans Fredlund, Magnus Unemo ' (2010 ) 86 Sex Transm Infect : 454 -460.

    • Search Google Scholar
  • Carannante, A., Prignano, G., Cusini, M., Matteelli, A., Dal Conte, I., Ghisetti, V., D’Antuono, A., Cavrini, F., Antonetti, R., Stefanelli, P.: Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010. Clin Microbiol Infect 8, 558–564 (2012).

    Stefanelli P. , 'Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010 ' (2012 ) 8 Clin Microbiol Infect : 558 -564.

    • Search Google Scholar
  • Camara, J., Serra, J., Ayats, J., Bastida, T., Carnicer-Pont, D., Andreu, A., Ardanuy, C.: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 67, 1858–1860 (2012).

    Ardanuy C. , 'Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain ' (2012 ) 67 J Antimicrob Chemother : 1858 -1860.

    • Search Google Scholar
  • Chisholm, S.A., Unemo, M., Quaye, N., Johansson, E., Cole, M.J., Ison, C.A., Van de Laar, M.J.:. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill 18, 20358 (2013).

    Van de Laar M.J. , 'Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone ' (2013 ) 18 Euro Surveill : 20358 -.

    • Search Google Scholar
  • Tapsall, J.W.: Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis 41, 263–268 (2005).

    Tapsall J.W. , 'Antibiotic resistance in Neisseria gonorrhoeae ' (2005 ) 41 Clin Infect Dis : 263 -268.

    • Search Google Scholar
  • Martin, I.M., Ison, C.A., Aanensen, D.M., Fenton, K.A., Spratt, B.G.: Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 189, 1497–1505 (2004).

    Spratt B.G. , 'Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area ' (2004 ) 189 J Infect Dis : 1497 -1505.

    • Search Google Scholar
  • Módszertani ajánlás a szexuális úton terjedő infekciók kivizsgálására és kezelésére/ Methodological letter of detection of sexually transmitted infections and treatment. Egészségügyi Közlöny/Health Bulletin 52, 1509–1518 (2002).

  • Országos Epidemiológiai Központ (OEK)/National Epidemiological Center: Szexuális úton terjedő betegségek Magyarországon/Sexually transmitted diseases in Hungary 2013. IV. Epinfo 5, 45–50 (2014).

    'Szexuális úton terjedő betegségek Magyarországon/Sexually transmitted diseases in Hungary 2013. IV ' (2014 ) 5 Epinfo : 45 -50.

    • Search Google Scholar
  • Shimuta, K., Unemo, M., Nakayama, S., Morita-Ishihara, T., Dorin, M., Kawahata, T., Ohnishi, M.: Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother 57, 5225–5232 (2013).

    Ohnishi M. , 'Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance ' (2013 ) 57 Antimicrob Agents Chemother : 5225 -5232.

    • Search Google Scholar
  • Martin, I., Sawatzky, P., Liu, G., Allen, V., Lefebvre, B., Hoang, L., Lovgren, M., Haldane, D., Caeseele, P.V., Horsman, G., Garceau, R., Ratnam, S., Wong, T., Gilmour, M.: Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010. Can J Microbiol 59, 671–678 (2013).

    Gilmour M. , 'Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010 ' (2013 ) 59 Can J Microbiol : 671 -678.

    • Search Google Scholar
  • European Centre for Diseases Prevention and Control (ECDC): Technical Report. Molecular typing of Neisseria gonorrhoeae. Results from a Pilot Study 2010–2011. Stockholm: ECDC, 2012.

    '', in Technical Report. Molecular typing of Neisseria gonorrhoeae. Results from a Pilot Study 2010–2011 , (2012 ) -.

  • Endimiani, A., Guilarte, Y.N., Tinguely, R., Hirzberger, L., Selvini, S., Lupo, A., Hauser, C., Furrer, H.:. Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998–2012): Emergence of multidrug-resistant clones less susceptible to cephalosporins. BMC Infect Dis 25, 106 (2014).

    Furrer H. , 'Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998–2012): Emergence of multidrug-resistant clones less susceptible to cephalosporins ' (2014 ) 25 BMC Infect Dis : 106 -.

    • Search Google Scholar
  • Mlynarczyk-Bonikowska, B., Serwin, A.B., Golparian, D., Walter de Walthoffen, S., Majewski, S., Koper, M., Malejczyk, M., Domeika, M., Unemo, M.: Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010–2012. BMC Infect Dis 14, 65 (2014).

    Unemo M. , 'Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010–2012 ' (2014 ) 14 BMC Infect Dis : 65 -.

    • Search Google Scholar
  • Olsen, B., Lan, P.T., Golparian, D., Johansson, E., Tran, H.K., Unemo, M.: Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis 13, 40 (2013).

    Unemo M. , 'Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011 ' (2013 ) 13 BMC Infect Dis : 40 -.

    • Search Google Scholar
  • Unemo, M., Golparian, D., Stary, A., Eigentler, A.: First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 16(43), 19998 (2011).

    Eigentler A. , 'First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011 ' (2011 ) 16 Euro Surveill : 19998 -.

    • Search Google Scholar
  • Unemo, M., Golparian, D., Syversen, G., Vestrheim, D.F., Moi, H.: Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 15(47), 19721 (2010).

    Moi H. , 'Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010 ' (2010 ) 15 Euro Surveill : 19721 -.

    • Search Google Scholar
  • Ison, C.A., Hussey, J., Sankar, K.N., Evans, J., Alexander, S.: Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. 16(14), 19833 (2011).

    Alexander S. , 'Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010 ' (2011 ) 16 Euro Surveill. : 19833 -.

    • Search Google Scholar
  • Allen, V.G., Mitterni, L., Seah, C., Rebbapragada, A., Martin, I.E., Lee, C., Siebert, H., Towns, L., Melano, R.G., Low, D.E.: Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 309, 163–170 (2013).

    Low D.E. , 'Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada ' (2013 ) 309 JAMA : 163 -170.

    • Search Google Scholar
  • Tapsall, J., Read, P., Carmody, C., Bourne, C., Ray, S., Limnios, A., Sloots, T., Whiley, D.: Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 58, 683–687 (2009).

    Whiley D. , 'Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods ' (2009 ) 58 J Med Microbiol : 683 -687.

    • Search Google Scholar
  • Boslego, J.W., Tramont, E.C., Takafuji, E.T., Diniega, B.M., Mitchell, B.S., Small, J.W., Khan, W.N., Stein, D.C.: Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 317, 272–278 (1987).

    Stein D.C. , 'Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae ' (1987 ) 317 N Engl J Med : 272 -278.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 3 0 0
May 2021 1 0 0
Jun 2021 1 0 0
Jul 2021 5 0 0
Aug 2021 3 1 1
Sep 2021 5 0 0
Oct 2021 0 0 0